Here are the DEF 14A proxy statements from LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock (LFMDP) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow LFMDP and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full LFMDP filings page.
LifeMD, Inc. has issued its 2026 proxy statement for a virtual annual meeting on June 12, 2026, asking stockholders to elect seven directors, ratify PricewaterhouseCoopers as auditor, approve changes to its equity plan, and authorize possible adjournment of the meeting.
The Fourth Amended and Restated 2020 Equity and Incentive Plan would add 3,000,000 shares, remove the evergreen annual share increase, tighten share-counting rules, and prohibit option repricing without stockholder approval. The filing also describes a “little r” restatement-driven clawback of 392,000 shares of performance stock, valued at $1,336,720, and notes that 2025 formula bonuses under the corporate plan paid out at 0%, with the CEO’s 2025 total compensation at $777,075.